0078-0709-94 |
0078-0709 |
HUMAN PRESCRIPTION DRUG |
TABRECTA |
capmatinib |
TABLET, FILM COATED |
ORAL |
20200506 |
N/A |
NDA |
NDA213591 |
Novartis Pharmaceuticals Corporation |
CAPMATINIB HYDROCHLORIDE |
150 mg/1 |
56 TABLET, FILM COATED in 1 BOTTLE (0078-0709-94) |
0078-0716-56 |
0078-0716 |
HUMAN PRESCRIPTION DRUG |
TABRECTA |
capmatinib |
TABLET, FILM COATED |
ORAL |
20200506 |
N/A |
NDA |
NDA213591 |
Novartis Pharmaceuticals Corporation |
CAPMATINIB HYDROCHLORIDE |
200 mg/1 |
56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-56) |
0078-0716-94 |
0078-0716 |
HUMAN PRESCRIPTION DRUG |
TABRECTA |
capmatinib |
TABLET, FILM COATED |
ORAL |
20200506 |
N/A |
NDA |
NDA213591 |
Novartis Pharmaceuticals Corporation |
CAPMATINIB HYDROCHLORIDE |
200 mg/1 |
56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-94) |
0078-0709-56 |
0078-0709 |
HUMAN PRESCRIPTION DRUG |
TABRECTA |
capmatinib |
TABLET, FILM COATED |
ORAL |
20200506 |
N/A |
NDA |
NDA213591 |
Novartis Pharmaceuticals Corporation |
CAPMATINIB HYDROCHLORIDE |
150 mg/1 |
56 TABLET, FILM COATED in 1 BOTTLE (0078-0709-56) |